Literature DB >> 16369632

Severe anemia.

A Shih1, R E Kassanoff, B Altrabulsi.   

Abstract

Entities:  

Year:  2001        PMID： 16369632      PMCID： PMC1305832          DOI： 10.1080/08998280.2001.11927775

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


× No keyword cloud information.
  8 in total

1.  Parvovirus B19-related anemia in an HIV-infected patient: rapid control after production of neutralizing antibodies during highly active antiretroviral therapy.

Authors:  J R Arribas; J M Peña; J E Echevarría
Journal:  Ann Intern Med       Date:  2000-06-20       Impact factor: 25.391

2.  Unusual bone marrow manifestations of parvovirus B19 infection in immunocompromised patients.

Authors:  T W Crook; B B Rogers; R D McFarland; S H Kroft; P Muretto; J A Hernandez; M J Latimer; R W McKenna
Journal:  Hum Pathol       Date:  2000-02       Impact factor: 3.466

Review 3.  The syndrome of thymoma and erythroblastopenic anemia. A review of 56 cases including 3 case reports.

Authors:  E Hirst; T I Robertson
Journal:  Medicine (Baltimore)       Date:  1967-05       Impact factor: 1.889

4.  Erythrocyte P antigen: cellular receptor for B19 parvovirus.

Authors:  K E Brown; S M Anderson; N S Young
Journal:  Science       Date:  1993-10-01       Impact factor: 47.728

Review 5.  Molecular, cellular and clinical aspects of parvovirus B19 infection.

Authors:  K E Brown; N S Young; J M Liu
Journal:  Crit Rev Oncol Hematol       Date:  1994-02       Impact factor: 6.312

6.  Chronic pure red cell aplasia caused by parvovirus B19 in AIDS: use of intravenous immunoglobulin--a report of eight patients.

Authors:  P R Koduri; R Kumapley; J Valladares; C Teter
Journal:  Am J Hematol       Date:  1999-05       Impact factor: 10.047

7.  Red cell aplasia responsive to immunoglobulin therapy as initial manifestation of human immunodeficiency virus infection.

Authors:  F Gottlieb; J Deutsch
Journal:  Am J Med       Date:  1992-03       Impact factor: 4.965

8.  Parvovirus B19 as a cause of acquired chronic pure red cell aplasia.

Authors:  N Frickhofen; Z J Chen; N S Young; B J Cohen; H Heimpel; J L Abkowitz
Journal:  Br J Haematol       Date:  1994-08       Impact factor: 6.998
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.